FDA gives thumbs down to MDMA for now, demanding further research The much-anticipated decision has rattled supporters of psychedelic therapies. The drugmaker says it will ask the agency to reconsider. Will Stone
Transplant surgeons are using a new, controversial procedure to retrieve organs Many transplant programs are using a controversial procedure called normothermic regional perfusion to obtain organs from donors. After a donor is declared dead, circulation is restarted with a pump. Rob Stein
FDA approves a second Alzheimer's drug that can modestly slow disease The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment. The Associated Press
Rapamycin is being studied to see if it can slow down age-related diseases in humans By testing the drug rapamycin as a way to prevent gum disease — often associated with heart disease and dementia — researchers may learn more about if it slows age-related diseases. Allison Aubrey
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics Psychedelics researchers and investors are still reeling from last week’s no vote for MDMA by a panel of advisers to the FDA. Will Stone
Once called Nantucket fever, this nasty tick-borne illness is on the rise Once called Nantucket fever, the tick-borne illness babesios is spreading from the Northeast into the Midwest. A clinical trial starts this month to see if an anti- malaria drug can treat the disease. Allison Aubrey
Out-of-state abortions have risen in Washington since 2022 The number of out-of-state women coming to Washington for abortions went up after 2022, when national protections for abortion care ended, according to a new assessment from University of Washington Medicine. Dyer Oxley
Lots of drug companies talk about putting patients first — but this one actually did When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn't work, the company took the unusual step of voluntarily pulling it off the market. Jon Hamilton
He invented a successful medical device as a student. Here's his advice for new grads When Thorsten Siess was in graduate school, he came up with the idea for a heart device that's now been used in hundreds of thousands of patients around the world. Sydney Lupkin
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them. Will Stone
